Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's GDUFA War Chest Grows, And Industry May Look For Lower Fees

Executive Summary

Two years into collecting generic user fees, FDA has more than $277 million in unspent dollars.

Advertisement

Related Content

Generic User Fee Talks Reach 'Final Wording' But Still Not Done
ANDA User Fees Offer Sponsor Relief, But More Facility Pain
Shutdown Week Two: Could Sponsors Find A More Focused FDA?
Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree

Topics

Advertisement
UsernamePublicRestriction

Register

PS056919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel